MMP2 and malignant colon neoplasm: When miR-29b activity is silenced by transfecting colon cancer cells with a miRVana miR-29b Inhibitor (Figure S1), HAG has no effect on reduction of MMP-2 expression (Figures 2C, 2E and 2G) and to some extent induced the MMP-2 expression.